Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

Not Applicable

Completed

• Conditions: Pancreatic Cancer

• Registration Number: NCT00767273
• Lead Sponsor: Stanford University

Brief Summary

To test the ability of new imaging techniques to monitor and predict response of pancreatic cancer to radiation and/or chemotherapy.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2006-10
• Primary Completion: 2007-12
• Study Completion: 2007-12
• Study First Submitted: 2008-10-03
• Study First Submitted QC: 2008-10-06
• Study First Posted: 2008-10-07
• Status Verified: 2012-06
• Last Update Submitted: 2012-06-07
• Last Update Posted: 2012-06-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Adult patients (>18) with histologically confirmed adenocarcinomas of the pancreas with a - treatment plan consisting of definitive or palliative radiation therapy and/or chemotherapy with or without surgery.

• Negative urine pregnancy test if a woman of child-bearing potential (WOCBP).
• WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study period.
• All patients will be evaluated in a uniform manner at the Stanford GI Combined Modality Tumor Board to determine eligibility.

Read More

Exclusion Criteria

1. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.

2. Any concurrent malignancy other than non-melanomaskin cancer, or carcinomainsitu of the cervix. Patients with a previous malignancy without evidence of disease for >5 years will be allowed to enter the trial.

3. WOCBP who is pregnant or breastfeeding. 4. Inability to sign written consent.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Evaluate the performance of the novel imaging methods

Secondary Outcome Measures

Name	Time	Method
Correlate FLT activity with clinical outcomes

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States